Company news

Canntab Therapeutics Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Canntab Therapeutics Featured in the Canadian Cannabis Investor Magazine

June 24, 2019

InvestmentPitch Media Video Discusses Canntab's Term Sheet with Heritage Cannabis to Process Hemp into High Quality CBD Oil for Canntab's Gelcaps - Video Available on Investmentpitch.com

May 31, 2019

Canntab signs term sheet with Heritage for processing hemp for sale of CBD filled gelcaps

May 30, 2019

InvestmentPitch Media Video Discusses Canntab's Receipt of Cultivation Licence from Health Canada to Grow Industrial Hemp - Video Available on Investmentpitch.com

May 22, 2019

Canntab Receives Cultivation Licence for Industrial Hemp

May 21, 2019

Canntab Therapeutics Now Trading on the OTCQX Best Market

May 1, 2019

InvestmentPitch Media Video Discusses Canntab Approaching Revenue under FSD Pharma's New "Sale for Medical Purposes" Cannabis License - Video Available on Investmentpitch.com

April 24, 2019

Canntab Advances its Revenue Model with Recent Sales License Approval for FSD Pharma from Health Canada

April 23, 2019

FSD Pharma Receives Cannabis Sales License from Health Canada

April 22, 2019

InvestmentPitch Media Video Discusses Canntab Therapeutics and its Application to Become a Licensed Producer Under ACMPR with Health Canada - Video News Alert on Investmentpitch.com

October 22, 2018

Canntab Files Application to Become Licensed Producer

October 18, 2018

Canntab Therapeutics, Extended Release Cannabis Tablets, CEO Clip Video

October 4, 2018

InvestmentPitch Media Video Discusses Canntab Therapeutics LOI With NewCanna of Colombia to Distribute Canntab Products in Select Countries - Video News Alert on Investmentpitch.com

October 4, 2018

Canntab Enters LOI for Bi-Lateral Sales & Distribution and Cannabis Oil Supply

October 1, 2018

Canntab Added to CSE Composite Index

September 24, 2018

Canntab Sets New All-Time High Trading Prices and Volume

September 20, 2018

Canntab Exceeds All-Time High Trading Prices and Grants Options

September 19, 2018

Canntab and Emblem Announce Positive Results on Testing: Proceeding to Clinical Trials

September 18, 2018

Canntab Signs Collaboration and Profit Sharing Agreement with FSD Pharma for Production and Market of Oral Dose Delivery Platforms

September 18, 2018

Canntab Engages Industry Leader Lorne Gertner as Consultant

July 16, 2018

InvestmentPitch Media Video Discusses Canntab Therapeutics LOI with FSD Pharma to Obtain License to Process and Sell Cannabis Based Products - Video News Alert on Investmentpitch.com

July 11, 2018

Canntab announces collaboration and profit sharing agreement with FSD Pharma to produce and market oral dose delivery platforms

July 9, 2018

Canntab Announces Launch of Innovative Hemp Oil Capsules

June 20, 2018

Canntab Announces Director Resignation

June 14, 2018

Canntab Therapeutics Files 2 New Canadian Patent Applications Related to Pharmaceutical Cannabis

May 25, 2018

Canntab Appoints Bob Woloschuk to Advisory Board

May 17, 2018

Canntab Provides Clarification on CFN Media Engagement

May 15, 2018

Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation

May 14, 2018

Canntab Therapeutics Files 11 Patent Applications Related to Pharmaceutical Cannabis

April 26, 2018

Canntab Provides Corporate Update

April 24, 2018

← Newer news releases

Decks

The 5 newest of 8 decks. Every deck is listed under its year.